LivaNova PLC | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$4.49 |
Market Cap |
$3.51 B |
Shares Outstanding |
48.32 M |
Public Float |
48.44 M |
Address |
20 Eastbourne Terrace London Greater London W2 6LG United Kingdom |
Employees | - |
Website | http://www.livanova.com |
Updated | 07/08/2019 |
LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the Cardiac Surgery and Neuromodulation, and Other Corporate segments. The Cardiac Surgery and Neuromodulation segment corresponds to the primary therapeutic areas. |